Gynecologic oncology
-
Gynecologic oncology · Sep 1998
Multicenter Study Clinical TrialA phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
To determine the response rate and associated toxicity of weekly CPT-11 in squamous carcinoma of the cervix. ⋯ OFFis schedule of CPT-11 exhibits modest activity with moderate toxicity in patients with recurrent squamous carcinoma of the cervix.